Hiroaki Kusaka

1.7k total citations · 1 hit paper
28 papers, 1.3k citations indexed

About

Hiroaki Kusaka is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Nephrology. According to data from OpenAlex, Hiroaki Kusaka has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Nephrology. Recurrent topics in Hiroaki Kusaka's work include Cardiovascular Function and Risk Factors (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Hiroaki Kusaka is often cited by papers focused on Cardiovascular Function and Risk Factors (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Hiroaki Kusaka collaborates with scholars based in Japan, United States and Austria. Hiroaki Kusaka's co-authors include Shokei Kim‐Mitsuyama, Nobutaka Koibuchi, Yu Hasegawa, Hisao Ogawa, Daisuke Sueta, Shinji Murosaki, Yasunobu Yoshikai, Bo-Wen Lin, Yoshihiro Yamamoto and Ken Uekawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stroke and Scientific Reports.

In The Last Decade

Hiroaki Kusaka

25 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

2014 336 citations Bo-Wen Lin, Nobutaka Koibuchi et al. Cardiovascular Diabetology profile →

Peers

Countries citing papers authored by Hiroaki Kusaka

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Kusaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kusaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kusaka more than expected).

Fields of papers citing papers by Hiroaki Kusaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kusaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kusaka. The network helps show where Hiroaki Kusaka may publish in the future.

Co-authorship network of co-authors of Hiroaki Kusaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kusaka. A scholar is included among the top collaborators of Hiroaki Kusaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kusaka. Hiroaki Kusaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interventional diagnostic procedures in INOCA: an essential approach in ischemic heart disease 2025 ·Cardiovascular Intervention and Therapeutics ·(unknown), Masanobu Ishii, Hiroaki Kusaka, Takayoshi Yamashita, Eiichiro Yamamoto, (unknown)	0
2	Current Overview of Diagnostic and Treatment Strategies for Ischemia with Non-obstructive Coronary Artery Disease 2024 ·(unknown), Masanobu Ishii, Yasuhiro Otsuka, (unknown), Koichiro Fujisue, Noriaki Tabata, Kenshi Yamanaga, Hiroaki Kusaka, Yasushi Matsuzawa, Eiichiro Yamamoto, Kenichi Tsujita	0
3	Current Overview of Myocardial Infarction with Non-Obstructive Coronary Arteries 2024 ·Yasuhiro Otsuka, Masanobu Ishii, (unknown), (unknown), Koichiro Fujisue, Noriaki Tabata, Kenshi Yamanaga, Hiroaki Kusaka, Yasushi Matsuzawa, Eiichiro Yamamoto, Kenichi Tsujita	0
4	Association of Early Administration of Furosemide with Improved Oxygenation in Patients with Acute Heart Failure 2021 ·ESC Heart Failure ·(unknown), Masanobu Ishii, Nobuyasu Yamamoto, Kyohei Marume, Michikazu Nakai, Soshiro Ogata, (unknown), (unknown), Takayuki Mōri, (unknown), Hiroaki Kusaka, (unknown), (unknown), Yoshitaka Iwanaga, Hisao Ogawa, Yoshihiro Miyamoto, Kenichi Tsujita	7
5	Incidence Rate of Acute Coronary Syndrome Including Acute Myocardial Infarction, Unstable Angina, and Sudden Cardiac Death in Nobeoka City for the Super-Aged Society of Japan 2021 ·Circulation Journal ·Soshiro Ogata, Kyohei Marume, Michikazu Nakai, (unknown), Masanobu Ishii, (unknown), Takayuki Mōri, (unknown), Hiroaki Kusaka, (unknown), (unknown), Yoshitaka Iwanaga, Takao Yano, Nobuyasu Yamamoto, Yoshihiro Miyamoto	6
6	Primary cardiac angiosarcoma directly invading the right lung: An autopsy report 2021 ·SHILAP Revista de lepidopterología ·(unknown), Akira Ishihara, (unknown), Hiroaki Kusaka, Hiroaki Kataoka	3
7	Prognostic impact of the presence of on-duty cardiologist on patients with acute myocardial infarction admitted during off-hours 2020 ·Journal of Cardiology ·Kyohei Marume, (unknown), Nobuyasu Yamamoto, (unknown), Takayuki Mōri, (unknown), Masanobu Ishii, Hiroaki Kusaka, (unknown), (unknown), (unknown), Seiji Takashio, Yuichiro Arima, Kenji Sakamoto, Eiichiro Yamamoto, Koichi Kaikita, Kenichi Tsujita	7
8	Clinical Significance of Pulse Pressure in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction 2016 ·European Journal of Heart Failure ·Takanori Tokitsu, Eiichiro Yamamoto, Yoshihiro Hirata, Hiroaki Kusaka, Koichiro Fujisue, Daisuke Sueta, Koichi Sugamura, Kenji Sakamoto, Kenichi Tsujita, Koichi Kaikita, Seiji Hokimoto, Seigo Sugiyama, Hisao Ogawa	27
9	Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome 2016 ·Cardiovascular Diabetology ·Hiroaki Kusaka, Nobutaka Koibuchi, Yu Hasegawa, Hisao Ogawa, Shokei Kim‐Mitsuyama	129
10	The Clinical Significance of Plasma Neopterin in Heart Failure with Preserved Left Ventricular Ejection Fraction 2015 ·ESC Heart Failure ·Eiichiro Yamamoto, Yoshihiro Hirata, Takanori Tokitsu, Hiroaki Kusaka, Noriaki Tabata, Kenichi Tsujita, Megumi Yamamuro, Koichi Kaikita, Hiroshi Watanabe, Seiji Hokimoto, Toru Maruyama, Hisao Ogawa	26
11	ASK1 is involved in cognitive impairment caused by long-term high-fat diet feeding in mice 2015 ·Scientific Reports ·Kensuke Toyama, Nobutaka Koibuchi, Yu Hasegawa, Ken Uekawa, Osamu Yasuda, Daisuke Sueta, Takashi Nakagawa, Mingjie Ma, Hiroaki Kusaka, Bo-Wen Lin, Hisao Ogawa, Hidenori Ichijo, Shokei Kim‐Mitsuyama	20
12	Low-Normal Serum Sodium and Heart Failure-Related Events in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction 2015 ·Circulation Journal ·Hiroaki Kusaka, Seigo Sugiyama, Eiichiro Yamamoto, Eiichi Akiyama, Yasushi Matsuzawa, Yoshihiro Hirata, Koichiro Fujisue, Hirofumi Kurokawa, Junichi Matsubara, Koichi Sugamura, Hirofumi Maeda, Hideaki Jinnouchi, Kunihiko Matsui, Hisao Ogawa	18
13	DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure 2014 ·Cardiovascular Diabetology ·Nobutaka Koibuchi, Yu Hasegawa, Tetsuji Katayama, Kensuke Toyama, Ken Uekawa, Daisuke Sueta, Hiroaki Kusaka, (unknown), Takashi Nakagawa, Bo-Wen Lin, Shokei Kim‐Mitsuyama	51
14	Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice breakdown → 2014 ·Cardiovascular Diabetology ·Bo-Wen Lin, Nobutaka Koibuchi, Yu Hasegawa, Daisuke Sueta, Kensuke Toyama, Ken Uekawa, Mingjie Ma, Takashi Nakagawa, Hiroaki Kusaka, Shokei Kim‐Mitsuyama	336
15	Endothelial function and cardiovascular events in chronic kidney disease 2014 ·International Journal of Cardiology ·Yoshihiro Hirata, Seigo Sugiyama, Eiichiro Yamamoto, Yasushi Matsuzawa, Eiichi Akiyama, Hiroaki Kusaka, Koichiro Fujisue, Hirofumi Kurokawa, Junichi Matsubara, Koichi Sugamura, Hirofumi Maeda, Satomi Iwashita, Hideaki Jinnouchi, Kunihiko Matsui, Hisao Ogawa	47
16	High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction 2014 ·Heart and Vessels ·Yuichi Kimura, Yasuhiro Izumiya, Shinsuke Hanatani, Eiichiro Yamamoto, Hiroaki Kusaka, Takanori Tokitsu, Seiji Takashio, Kenji Sakamoto, Kenichi Tsujita, Tomoko Tanaka, Megumi Yamamuro, Sunao Kojima, Shinji Tayama, Koichi Kaikita, Seiji Hokimoto, Hisao Ogawa	32
17	Therapy with the Combination of Amlodipine and Irbesartan Has Persistent Preventative Effects on Stroke Onset Associated with BDNF Preservation on Cerebral Vessels in Hypertensive Rats 2014 ·Translational Stroke Research ·Yu Hasegawa, Takashi Nakagawa, Ken Uekawa, Mingjie Ma, Bo-Wen Lin, Hiroaki Kusaka, Tetsuji Katayama, Daisuke Sueta, Kensuke Toyama, Nobutaka Koibuchi, Shokei Kim‐Mitsuyama	19
18	Growth Differentiation Factor-15 Is a Useful Prognostic Marker in Patients With Heart Failure With Preserved Ejection Fraction 2013 ·Canadian Journal of Cardiology ·Yasuhiro Izumiya, Shinsuke Hanatani, Yuichi Kimura, Seiji Takashio, Eiichiro Yamamoto, Hiroaki Kusaka, Takanori Tokitsu, Taku Rokutanda, Satoshi Araki, Kenichi Tsujita, Tomoko Tanaka, Megumi Yamamuro, Sunao Kojima, Shinji Tayama, Koichi Kaikita, Seiji Hokimoto, Hisao Ogawa	65
19	Immunopotentiating Activity of Nigerooligosaccharides for the T Helper 1-Like Immune Response in Mice 1999 ·Bioscience Biotechnology and Biochemistry ·Shinji Murosaki, Koutarou Muroyama, Yoshihiro Yamamoto, Hiroaki Kusaka, (unknown), Yasunobu Yoshikai	66
20	Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen–specific IgE production by stimulation of IL-12 production in mice 1998 ·Journal of Allergy and Clinical Immunology ·Shinji Murosaki, Yoshihiro Yamamoto, Kazue Ito, (unknown), Hiroaki Kusaka, Hitoshi Ikeda, Yasunobu Yoshikai	239

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact